🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokine...
Status
Not Yet Recruiting
Location
No.49, Huayuan North Road, Haidian District, Beijing City
Start Date
2025-03-07
Trial ID
NCT06867406
Treatments Being Tested
A Phase 1, Randomized, Double-blind, Placebo-controlled Study of Orally Adm...
Status
Completed
Location
Labcorp Cru
Start Date
2022-08-08
Trial ID
NCT05349097
Treatments Being Tested
This is a randomized, double-blind, and placebo-controlled phase I clinical...
Status
Completed
Location
The Second Hospital of Anhui Medical University
Start Date
2022-08-08
Trial ID
NCT05504746
Treatments Being Tested
This is a phase 1, 2-part, double-blind (sponsor-unblinded), randomized, pl...
Status
Terminated
Location
GSK Investigational Site
Start Date
2019-06-17
Trial ID
NCT03984812
Treatments Being Tested
A Phase 1, Partially Blind, Placebo Controlled, Randomized, Combined Single...
Status
Completed
Location
Worldwide Clinical Trials
Start Date
2020-06-08
Trial ID
NCT04493671
Treatments Being Tested
A Phase Ⅰ, Single and Multiple Ascending Dose escalation, and Food-Effect S...
Status
Completed
Location
Beijing Municipality - Beijing Municipality - No. 101, Luyuan East Road, Tongzhou District, Beijing
Start Date
2025-09-04
Trial ID
NCT07616791
Treatments Being Tested
This randomized, double-blind study will assess the safety, pharmacokinetic...
Status
Completed
Location
Auckland Clinical Studies Ltd
Start Date
2016-01-10
Trial ID
NCT02652377
The aim of this 4-weeks randomized double-blind placebo-controlled single a...
Status
Completed
Location
Clinical Research Unit
Start Date
2020-03-16
Trial ID
NCT06040372
The study is being conducted to evaluate the safety, tolerability, pharmaco...
Status
Unknown
Location
The First Affiliated Hospital of China University of Science and Technology
Start Date
2023-04-30
Trial ID
NCT05808374
This is a randomized, double-blind, placebo-controlled, single- and multipl...
Status
Terminated
Location
First OC Dermatology Research
Start Date
2023-05-10
Trial ID
NCT05859724